Cargando…

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

BACKGROUND: Previous studies suggested that obesity and diabetes were correlated with breast cancer outcome. The aim of the present study was to investigate the prognostic effect of obesity and diabetes on the outcome of early breast cancer patients. MATERIALS AND METHODS: Overall, 841 early breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, Pensabene, Matilde, De Laurentiis, Michelino, Augustin, Livia Silvia Adriana, Amore, Alfonso, D'Aiuto, Massimiliano, Tortoriello, Raffaele, Accurso, Antonello, Cavalcanti, Ernesta, Botti, Gerardo, Montella, Maurizio, De Placido, Sabino, Arpino, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777806/ https://www.ncbi.nlm.nih.gov/pubmed/29383194 http://dx.doi.org/10.18632/oncotarget.22977

Ejemplares similares

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study
por: Buono, Giuseppe, et al.
Publicado: (2020)

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
por: Capasso, Immacolata, et al.
Publicado: (2014)

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial
por: Capasso, Immacolata, et al.
Publicado: (2013)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
por: Gargiulo, Piera, et al.
Publicado: (2016)

Tumor characteristics and prognosis in familial breast cancer
por: Arpino, G., et al.
Publicado: (2016)

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
por: Schettini, Francesco, et al.
Publicado: (2020)

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis
por: De Angelis, Carmine, et al.
Publicado: (2017)

Multi-gene panel testing increases germline predisposing mutations’ detection in a cohort of breast/ovarian cancer patients from Southern Italy
por: Nunziato, Marcella, et al.
Publicado: (2022)

Male Breast Cancer: From Molecular Genetics to Clinical Management
por: Pensabene, Matilde, et al.
Publicado: (2022)

It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature
por: Pensabene, Matilde, et al.
Publicado: (2018)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
por: Schettini, Francesco, et al.
Publicado: (2018)

Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
por: Caputo, Roberta, et al.
Publicado: (2023)

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience
por: Capasso, Immacolata, et al.
Publicado: (2013)

Metabolic syndrome, hyperinsulinaemia and body mass index as risk factors in breast cancer: National Cancer Institute of Naples experience
por: Capasso, I, et al.
Publicado: (2009)

Gail's model as first step for early diagnosis: National Cancer Institute of Naples experience
por: Capasso, I, et al.
Publicado: (2009)

Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients
por: Crispo, Anna, et al.
Publicado: (2023)

Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
por: Arpino, Grazia, et al.
Publicado: (2015)

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
por: Di Maio, Massimo, et al.
Publicado: (2023)

Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
por: Buonaiuto, Roberto, et al.
Publicado: (2022)

Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)
por: De Angelis, C., et al.
Publicado: (2021)

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial
por: Augustin, Livia S.A., et al.
Publicado: (2017)

Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach
por: Fabi, Alessandra, et al.
Publicado: (2022)

Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
por: Saponaro, Mariarosaria, et al.
Publicado: (2022)

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
por: Schettini, Francesco, et al.
Publicado: (2021)

Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: [ESMO Open Volume 6, Issue 2, April 2021, 100054]
por: De Angelis, C., et al.
Publicado: (2021)

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
por: Isgrò, Maria Antonietta, et al.
Publicado: (2021)

Two novel sequence variants in MSH2 gene in a patient who underwent cancer genetic counseling for a very early-onset epithelial ovarian cancer
por: Pensabene, Matilde, et al.
Publicado: (2016)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020)

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
por: Piezzo, Michela, et al.
Publicado: (2020)

The Dynamic Optical Breast Imaging in the Preoperative Workflow of Women with Suspicious or Malignant Breast Lesions: Development of a New Comprehensive Score
por: D'Aiuto, Massimiliano, et al.
Publicado: (2012)

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

Rare tumours of the breast
por: Esposito, Emanuela, et al.
Publicado: (2019)

A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life
por: Chirico, Andrea, et al.
Publicado: (2017)

Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications
por: De Placido, S, et al.
Publicado: (2017)

Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial
por: Porciello, Giuseppe, et al.
Publicado: (2020)

Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial
por: Porciello, Giuseppe, et al.
Publicado: (2021)

Adenoma of the nipple: A clinicopathological report of 13 cases
por: DI BONITO, MAURIZIO, et al.
Publicado: (2014)

Active lifestyles in older adults: an integrated predictive model of physical activity and exercise
por: Galli, Federica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jlhr4h988cmhl1fh3u0bp70p2n